BICYCLE THERAPEUTICS PLC cotiza a 3.80 USD y tiene una capitalización bursátil de $266M. En los últimos 12 meses ha facturado $61M con un margen de flujo de caja libre del -347.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II cl…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.72 | $-0.87 | $-0.29 |
| Estimado | $-0.50 | $-0.58 | $-0.65 | $-0.95 |
| Sorpresa | — | -24.1% | -33.8% | +69.5% |
| Métrica | BCYC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -340.4% | -38.6% | -301.8% |
| Net Margin | -301.7% | -33.6% | -268.1% |
| FCF Margin | -347.2% | -13.9% | -333.3% |
| ROE | -35.9% | -40.4% | +4.5% |
| ROA | -30.5% | -32.0% | +1.5% |
| Current Ratio | 11.98 | 2.84 | +9.14 |
| Debt / Equity | — | 0.28 | — |